Related Experiment Videos

Enhanced phospholipase A2 and C activities of peripheral blood polymorphonuclear leukocytes from patients with

Insights

Rheumatoid arthritis patients

Area of Science:

  • Biochemistry
  • Immunology
  • Rheumatology

Background:

  • Elevated eicosanoid levels are characteristic of rheumatoid arthritis synovial fluid.
  • Polymorphonuclear leukocytes (PMN) constitute approximately 90% of cells in rheumatoid arthritis synovial fluid.
  • Eicosanoid precursor fatty acids are released by phospholipases from membrane phospholipids.

Purpose of the Study:

  • To investigate phospholipase A2 and C activities in peripheral blood PMN from rheumatoid arthritis patients.

Main Methods:

  • Collected peripheral blood PMN from rheumatoid arthritis patients and normal volunteers.
  • Assayed phospholipase A2 and C activities in PMN using various phospholipid substrates.

Main Results:

  • Rheumatoid arthritis PMN (RA-PMN) demonstrated significantly higher phospholipase A2 activity against phosphatidylcholine (PC) and phosphatidylethanolamine (PE) compared to normal PMN (N-PMN).
  • RA-PMN also exhibited greater phospholipase C activity against PC, PE, and phosphatidylinositol (PI) than N-PMN.

Conclusions:

  • Peripheral blood PMN in rheumatoid arthritis patients display enhanced phospholipase A2 and C activities.
  • These heightened enzymatic activities may contribute to increased eicosanoid production in rheumatoid arthritis.

Related Concept Videos